BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8867694)

  • 1. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
    Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
    Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas.
    Gottschalk J; Goebel S; Jautzke G; Martin H; Zimmer C; Märzheuser-Brands S; Cervós-Navarro J
    Histol Histopathol; 1992 Oct; 7(4):653-61. PubMed ID: 1360848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence].
    Crafa P; Campanini N; Martella EM; Trabattoni G; Tedeschi F
    Acta Biomed Ateneo Parmense; 1994; 65(5-6):297-308. PubMed ID: 8592922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.
    Demirtaş E; Yilmaz F; Ovül I; Oner K
    Acta Neurochir (Wien); 1996; 138(12):1456-63. PubMed ID: 9030354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas.
    Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G
    Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ag-NOR in meningiomas. Clinical and morphologic study of 14 cases].
    Cerdá-Nicolás M; Pérez-Bacet M; Piquer J; Barcia-Salorio JL
    Arch Neurobiol (Madr); 1992; 55(6):251-5. PubMed ID: 1492778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nucleolar organizer regions in meningiomas with reference to histopathological findings and recurrence].
    Hirayama H; Hara A; Niikawa S; Iwai T; Nishimura Y; Ando T; Sakai N; Yamada H; Takada M
    No To Shinkei; 1993 Apr; 45(4):355-61. PubMed ID: 8334021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar organizer regions in meningiomas. Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome.
    Plate KH; Ruschoff J; Mennel HD
    Anal Quant Cytol Histol; 1990 Dec; 12(6):429-38. PubMed ID: 2078265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions in meningiomas.
    Radhakrishnan VV; Radhakrishnan NS; Rout D; Misna BK
    Br J Neurosurg; 1993; 7(4):377-81. PubMed ID: 8216907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor proliferative fraction in infiltrating duct carcinoma.
    Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between the prognosis of retinoblastoma and proliferating cell nuclear antigen and argyrophilic protein at nucleolus organizer regions].
    Li D; Song X; Gao Y
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):293-6. PubMed ID: 10451965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive meningiomas in relation to high proliferating potential.
    Suwa T; Kawano N; Kameya T; Ito H; Oka H; Yada K
    Noshuyo Byori; 1993; 10(1):63-7. PubMed ID: 7693228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
    Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
    J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
    Zhao T; Zhang YL; Li CD
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human central nervous tumors].
    Sawada T; Oinuma T; Katada H; Saitoh M; Sakurai I
    Rinsho Byori; 1992 Nov; 40(11):1179-84. PubMed ID: 1284911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
    Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
    Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerized determination of proliferating cell nuclear antigen expression in meningiomas. A comparison with non-automated method.
    Konstantinidou A; Patsouris E; Kavantzas N; Pavlopoulos PM; Bouropoulou V; Davaris P
    Gen Diagn Pathol; 1997 Jun; 142(5-6):311-6. PubMed ID: 9228254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.